Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C for Bruises in Ischemic Stroke
NCT06823999Phase 4Not yet recruiting
- Sponsor
- Ditmanson Medical Foundation Chiayi Christian Hospital
- Start
- Aug 2025
- Primary completion
- Jul 2028
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of ascorbic acid in contusion and ischemic stroke (2 arms), sponsored by Ditmanson Medical Foundation Chiayi Christian Hospital. Primary endpoints: Rate of hematoma occurrence at 2 weeks and Hematoma resolution rate at 3 weeks. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
ascorbic acid
03
Conditions
contusionischemic stroke
Beyond the preview
Go deeper on NCT06823999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06823999.